Updates are available Correction dated 2025-03-24

Article History

Received: 17 October 2024

Accepted: 5 February 2025

First Online: 13 February 2025

Change Date: 24 March 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s12882-025-04055-w

Declarations

:

: The NorKiBB was approved by the Regional Committee for Medical Research Ethics Central Norway, as well as by the local data protection boards/data access committees in all of the participating hospitals’ ethics committees: the Data Protection Officer at St. Olavs Hospital, Trondheim University Hospital, Trondheim; the Regional Committee for Medical Research Ethics Western Norway for Haukeland University Hospital, Bergen; the Data Access Committee at Levanger Hospital, Levanger; the Data Protection Officer at Lillehammer Hospital, Lillehammer; the Data Protection Officer at Oslo University Hospital, Ullevål, Oslo; the Data Protection Office at Akershus Oslo University Hospital, Lørenskog; the Data Protection Official at the University Hospital of North Norway, Tromsø; and The Research Department at Stavanger University Hospital, Stavanger. All patients gave their written, informed consent after having received oral and written information about the project, possible disadvantages, and benefits in accordance with the General Data Protection Regulation (GDPR). A copy of the consent form is available in the Supplementary section. All experiments were performed in accordance with the Norwegian Act on medical and health research, and the Personal Data Act. The experiments were conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: MAØ: Has received salary from the Western Norway Regional Health Authority the last years on an unrelated project; has received an institutional research grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) on an unrelated project; has received a speaker’s fee from AstraZeneca. MGS: Has received an institutional research grant from the NIH-NIDDK, an institutional grant from Bayer Pharmaceuticals, NIH-NIA, NIDDK, NHLBI; consultant fees from Cricket Health; honoraria from Boehringer Ingelheim, Astra Zeneca, and Bayer Pharmaceuticals; payment from Hagens Berman International Law Firm. JI has received consulting fees from Astra Zeneca, Bayer Pharmaceuticals, and Jnana; support from Genentech. CA has received honoraria from Astra Zeneca, Boehringer Ingelheim. MDS has received honoraria from Astra Zeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Baxter, and Novartis; and participated in DSMB or AB of Viphor Pharma. All other authors declare no conflicts of interest.

: Not applicable.